发文地区与机构
近年国家 / 地区发文量统计
| 国家 / 地区 | 发文量 |
|---|---|
| USA | 234 |
| Canada | 46 |
| France | 43 |
| Italy | 42 |
| Netherlands | 42 |
| England | 38 |
| GERMANY (FED REP GER) | 27 |
| Mexico | 21 |
| Belgium | 20 |
| Spain | 19 |
近年机构发文量统计
| 机构 | 发文量 |
|---|---|
| CITY OF HOPE | 49 |
| UNIVERSITY OF ROCHESTER | 39 |
| MEMORIAL SLOAN KETTERING CANCER CENTER | 26 |
| UNICANCER | 26 |
| UNIVERSITY OF TEXAS SYSTEM | 26 |
| HARVARD UNIVERSITY | 25 |
| UNIVERSITY OF CALIFORNIA SYSTEM | 22 |
| INSTITUT NATIONAL DE LA SANTE ET DE LA ... | 21 |
| WASHINGTON UNIVERSITY (WUSTL) | 21 |
| OHIO STATE UNIVERSITY | 20 |
文章引用情况
1
The impact of changes in radiographic sarcopenia on overall survival in older adults undergoing different treatment pathways for pancreatic cancer2
Chemotherapy and radiation treatment decision-making experiences of older adults with cancer: A qualitative study3
Observed benefit and safety of aflibercept in elderly patients with metastatic colorectal cancer: An age-based analysis from the randomized placebo-controlled phase III VELOUR trial4
Functional impairment prior to major non-cardiac surgery is associated with mortality within one year in elderly patients with gastrointestinal, gynaecological and urogenital cancer: A prospective observational cohort study5
Circumstances of falls and fear of falling in community-dwelling older adults with cancer: Results from a mixed-methods study6
The use of chemotherapy in older patients with stage II and III colon cancer: Variation by age and era of diagnosis7
HER2-targeted treatment for older patients with breast cancer: An expert position paper from the International Society of Geriatric Oncology8
The preference to receive chemotherapy and cancer-related outcomes in older adults with breast cancer CALGB 49907 (Alliance)9
Potentially inappropriate medication use and associated healthcare utilization and costs among older adults with colorectal, breast, and prostate cancers10
Declining cancer incidence at the oldest ages: Hallmark of aging or lower diagnostic activity?